Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Inventory (2019 - 2025)

Eton Pharmaceuticals' Inventory history spans 7 years, with the latest figure at $16.9 million for Q3 2025.

  • For Q3 2025, Inventory rose 769.71% year-over-year to $16.9 million; the TTM value through Sep 2025 reached $16.9 million, up 769.71%, while the annual FY2024 figure was $15.2 million, 1572.01% up from the prior year.
  • Inventory for Q3 2025 was $16.9 million at Eton Pharmaceuticals, down from $23.8 million in the prior quarter.
  • Across five years, Inventory topped out at $23.8 million in Q2 2025 and bottomed at $334000.0 in Q3 2021.
  • The 5-year median for Inventory is $1.1 million (2023), against an average of $4.5 million.
  • The largest annual shift saw Inventory plummeted 80.34% in 2021 before it soared 1572.01% in 2024.
  • A 5-year view of Inventory shows it stood at $550000.0 in 2021, then grew by 1.27% to $557000.0 in 2022, then skyrocketed by 63.55% to $911000.0 in 2023, then skyrocketed by 1572.01% to $15.2 million in 2024, then grew by 10.66% to $16.9 million in 2025.
  • Per Business Quant, the three most recent readings for ETON's Inventory are $16.9 million (Q3 2025), $23.8 million (Q2 2025), and $13.6 million (Q1 2025).